{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:30:14Z","timestamp":1787679014523,"version":"build-2784847793"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Bone homeostasis only exists when the physical function of osteoblast and osteoclast stays in the balance between bone formation and resorption. Bone resorption occurs when the two processes are uncoupled, shifting the balance in favour of bone resorption. Excessive activation of osteoclasts leads to a range of osteolytic bone diseases including osteoporosis, aseptic prosthesis loosening, rheumatoid arthritis, and osteoarthritis. Receptor activator of nuclear factor kappa-B ligand (RANKL) and its downstream signaling pathways are recognized as key mediators that drive the formation and activation of osteoclastic function. Hence, osteoclast formation and\/or its function remain as dominant targets for research and development of agents reaching the treatment towards osteolytic diseases. Chrysin (CHR) is a flavonoid with a wide range of anti-inflammatory and anti-tumor effects. However, its effect on osteoclasts remains unknown. In this study, we found the effects of CHR on inhibiting osteoclast differentiation which were assessed in terms of the number and size of TRAcP positive multinucleated osteoclasts (OCs). Further, the inhibitory effects of CHR on bone resorption and osteoclast fusion of pre-OC were assessed by hydroxyapatite resorption pit assay and F-actin belts staining; respectively. Western blotting analysis of RANKL-induced signaling pathways and immunofluorescence analysis for p65 nuclear translocation in response to RANKL-induced osteoclasts were used to analyze the mechanism of action of CHR affecting osteoclasts. Lastly, the murine calvarial osteolysis model revealed that CHR could protect against particle-induced bone destruction <jats:italic>in vivo<\/jats:italic>. Collectively, our data strongly suggested that CHR with its promising anti-tumor effects would also be a potential therapeutic agent for osteolytic diseases.<\/jats:p>","DOI":"10.3389\/fphar.2022.793087","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T23:18:28Z","timestamp":1648509508000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Chrysin Protects Against Titanium Particle-Induced Osteolysis by Attenuating Osteoclast Formation and Function by Inhibiting NF-\u03baB and MAPK Signaling"],"prefix":"10.3389","volume":"13","author":[{"given":"Zuoxing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangsheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dairong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiji","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiake","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","article-title":"Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor kappaB (RANK) Receptors","volume":"190","author":"Arai","year":"1999","journal-title":"J. Exp. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast Differentiation and Activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"14667","DOI":"10.1074\/jbc.M901670200","article-title":"Myocyte Enhancer Factor 2 and Microphthalmia-Associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase D2 Promoter during RANKL-Induced Osteoclastogenesis","volume":"284","author":"Feng","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S0006291X18312543","DOI":"10.1016\/j.bbrc.2018.05.177","article-title":"G\u00f66983 Attenuates Titanium Particle-Induced Osteolysis and RANKL Mediated Osteoclastogenesis through the Suppression of NF\u03baB\/JNK\/p38 Pathways","author":"Feng","year":"2018","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.intimp.2016.10.008","article-title":"Inhibitory Effects of Flavonoids Extracted from Nepalese Propolis on the LPS Signaling Pathway","volume":"40","author":"Funakoshi-Tago","year":"2016","journal-title":"Int. Immunopharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/s0092-8674(02)00703-1","article-title":"Missing Pieces in the NF-kappaB Puzzle","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neulet.2010.08.064","article-title":"Chrysin Suppresses LPS-Stimulated Proinflammatory Responses by Blocking NF-\u039ab and JNK Activations in Microglia Cells","volume":"485","author":"Ha","year":"2010","journal-title":"Neurosci. Lett."},{"key":"B8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1365.035","article-title":"Bone Remodeling","volume":"1092","author":"Hadjidakis","year":"2006","journal-title":"Ann. N. Y Acad. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"47366","DOI":"10.1074\/jbc.M208284200","article-title":"U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells","volume":"277","author":"Hotokezaka","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1172\/JCI19657","article-title":"Critical Roles of C-Jun Signaling in Regulation of NFAT Family and RANKL-Regulated Osteoclast Differentiation","volume":"114","author":"Ikeda","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in Mice Lacking NF-kappaB1 and NF-kappaB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7564","DOI":"10.1016\/j.actbio.2013.03.010","article-title":"Titanium Particle-Challenged Osteoblasts Promote Osteoclastogenesis and Osteolysis in a Murine Model of Periprosthestic Osteolysis","volume":"9","author":"Jiang","year":"2013","journal-title":"Acta Biomater."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/jbmr.1973","article-title":"Lipoproteins Are an Important Bacterial Component Responsible for Bone Destruction through the Induction of Osteoclast Differentiation and Activation","volume":"28","author":"Kim","year":"2013","journal-title":"J. Bone Miner Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1210\/me.2007-0237","article-title":"NFATc1 Induces Osteoclast Fusion via Up-Regulation of Atp6v0d2 and the Dendritic Cell-specific Transmembrane Protein (DC-STAMP)","volume":"22","author":"Kim","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.clinbiochem.2012.03.021","article-title":"An Overview of the Regulation of Bone Remodelling at the Cellular Level","volume":"45","author":"Kular","year":"2012","journal-title":"Clin. Biochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0092-8674(00)81569-x","article-title":"Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1759720X16670154","article-title":"Bone Modeling and Remodeling: Potential as Therapeutic Targets for the Treatment of Osteoporosis","volume":"8","author":"Langdahl","year":"2016","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"B18","first-page":"1469","article-title":"Diphenylhydantoin Inhibits Osteoclast Differentiation and Function through Suppression of NFATc1 Signaling","volume":"24","author":"Masanori","year":"2010","journal-title":"J. Bone Mineral Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"26475","DOI":"10.1074\/jbc.M313973200","article-title":"Nuclear Factor of Activated T-Cells (NFAT) Rescues Osteoclastogenesis in Precursors Lacking C-Fos","volume":"279","author":"Matsuo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2302\/kjm.60.101","article-title":"Regulators of Osteoclast Differentiation and Cell-Cell Fusion","volume":"60","author":"Miyamoto","year":"2011","journal-title":"Keio J. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"35081","DOI":"10.1074\/jbc.C500353200","article-title":"Regulation of the Transcriptional Activity of C-Fos by ERK. A Novel Role for the Prolyl Isomerase PIN1","volume":"280","author":"Monje","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/molecules23061394","article-title":"Anti-Tumorigenic Activity of Chrysin from Oroxylum Indicum via Non-genotoxic P53 Activation through the ATM-Chk2 Pathway","volume":"23","author":"Nagasaka","year":"2018","journal-title":"Molecules"},{"key":"B23","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1111\/j.1749-6632.2011.06373.x","article-title":"New Regulation Mechanisms of Osteoclast Differentiation","volume":"1240","author":"Nakashima","year":"2015","journal-title":"Ann. N. Y Acad. Sci."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22002","article-title":"Antioxidant, Anti-inflammatory, and Enzyme Inhibitory Activity of Natural Plant Flavonoids and Their Synthesized Derivatives","volume":"32","author":"Nile","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B25","first-page":"461","article-title":"Natural Products as a Source of New Drugs","volume":"15","author":"Norman","year":"2002","journal-title":"Drug News Perspect."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.14670\/HH-19.1325","article-title":"Interaction between Osteoblast and Osteoclast: Impact in Bone Disease","volume":"19","author":"Phan","year":"2004","journal-title":"Histol. Histopathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e34132","DOI":"10.1371\/journal.pone.0034132","article-title":"Prevention of Wear Particle-Induced Osteolysis by a Novel V-ATPase Inhibitor Saliphenylhalamide through Inhibition of Osteoclast Bone Resorption","volume":"7","author":"Qin","year":"2012","journal-title":"Plos One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/jcp.26084","article-title":"Luteoloside Prevents Lipopolysaccharide-Induced Osteolysis and Suppresses RANKL-Induced Osteoclastogenesis through Attenuating RANKL Signaling Cascades","volume":"233","author":"Song","year":"2018","journal-title":"J. Cel. Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2008.10.146","article-title":"NF-kappaB Functions in Osteoclasts","volume":"378","author":"Soysa","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1399-0004.2010.01619.x","article-title":"Bone Resorption in Syndromes of the Ras\/MAPK Pathway","volume":"80","author":"Stevenson","year":"2011","journal-title":"Clin. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone Resorption by Osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.1074\/jbc.M115.678235","article-title":"Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate","volume":"291","author":"Thaler","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.drudis.2013.08.010","article-title":"Is Bisphosphonate Therapy Compromised by the Emergence of Adverse Bone Disorders","volume":"19","author":"Verron","year":"2014","journal-title":"Drug Discov. Today"},{"key":"B34","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/DDDT.S160020","article-title":"Chrysin Suppresses Proliferation, Migration, and Invasion in Glioblastoma Cell Lines via Mediating the ERK\/Nrf2 Signaling Pathway","volume":"12","author":"Wang","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2174\/1389450118666170321105425","article-title":"Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis","volume":"18","author":"Wang","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"B36","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/jcp.25907","article-title":"Artesunate Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption In Vitro and Prevents LPS-Induced Bone Loss In Vivo","volume":"233","author":"Wei","year":"2018","journal-title":"J. Cel Physiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/sj.gt.3302202","article-title":"Aseptic Loosening","volume":"11","author":"Wooley","year":"2004","journal-title":"Gene Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"827","DOI":"10.4315\/0362-028X.JFP-17-452","article-title":"Antioxidant and Antimicrobial Effects of Catechin Liposomes on Chinese Dried Pork","volume":"81","author":"Wu","year":"2018","journal-title":"J. Food Prot."},{"key":"B39","first-page":"17812","article-title":"Daphnetin Attenuates LPS-Induced Osteolysis and RANKL Mediated Osteoclastogenesis through Suppression of ERK and NFATc1 Pathways","volume-title":"J. Cell Physiol.","author":"Wu","year":"2019"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1359\/jbmr.2000.15.11.2178","article-title":"Cloning, Sequencing, and Functional Characterization of the Rat Homologue of Receptor Activator of NF-kappaB Ligand","volume":"15","author":"Xu","year":"2000","journal-title":"J. Bone Miner Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cytogfr.2008.11.007","article-title":"NF-kappaB Modulators in Osteolytic Bone Diseases","volume":"20","author":"Xu","year":"2009","journal-title":"Cytokine Growth Factor. Rev."},{"key":"B42","first-page":"1","article-title":"Current Research in the Pathogenesis of Aseptic Implant Loosening Associated with Particulate Wear Debris","volume":"79","author":"Yunpeng","year":"2013","journal-title":"Acta Orthopaedica Belgica"},{"key":"B43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1080\/01480545.2017.1384834","article-title":"Protective Effects of Chrysin on Sub-acute Diazinon-Induced Biochemical, Hematological, Histopathological Alterations, and Genotoxicity Indices in Male BALB\/c Mice","volume":"1","author":"Zeinali","year":"2017","journal-title":"Drug Chem. Toxicol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1002\/jcp.26508","article-title":"Bulleyaconitine A Prevents Ti Particle-Induced Osteolysis via Suppressing NF-\u039ab Signal Pathway during Osteoclastogenesis and Osteoblastogenesis","volume":"233","author":"Zhang","year":"2018","journal-title":"J. Cel. Physiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.793087\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T23:18:36Z","timestamp":1648509516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.793087\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":44,"alternative-id":["10.3389\/fphar.2022.793087"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.793087","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]},"article-number":"793087"}}